Latest Health News

Integral Diagnostics posts robust FY25 results with strong revenue growth and merger synergies exceeding expectations, setting a confident tone for FY26.

Integral Diagnostics Limited (ASX – IDX) reported a robust FY25 performance, boosted by its transformative merger with Capitol Health Limited. The company posted strong revenue and profit growth, declared a 4.0 cent final dividend, and outlined strategic priorities including AI adoption and teleradiology expansion.

EMVision Medical Devices is set to activate its sixth and final pivotal trial site at UCLA Health, advancing its emu™ brain scanner towards FDA submission. Meanwhile, the Continuous Innovation Study grows with the addition of Box Hill Hospital.

Tyro Payments delivered solid FY25 results with a 10.6% rise in EBITDA and accelerated growth initiatives, including expansion into new $40 billion addressable markets and a pilot banking platform.

CleanSpace Holdings Limited reported a 26% increase in revenue to $19.8 million for FY25, alongside a significant reduction in net loss to $478,276. The company’s strategic expansion and innovation efforts underpin its improving financial health and global market presence.

Prime Financial Group delivered a robust FY25 performance, with revenue climbing 21% and Funds Under Management soaring 58% following a key acquisition. The company sets sights on doubling revenue within five years.

Helloworld Travel Limited reported a mixed FY25 performance with an 8.6% decline in Total Transaction Value but a rise in underlying EBITDA, alongside a fully franked final dividend and a strategic acquisition in New Zealand.

Bio-Gene Technology Limited reported a net loss of AUD 2.58 million for FY2025 while making significant strides in developing its bio-insecticides Flavocide and Qcide, securing US Department of Defense grants and expanding global partnerships.

SPC Global Holdings is transitioning its senior financing from Scottish Pacific to Commonwealth Bank, locking in $154 million in total facilities and expected to save $3 million annually in interest. This move positions the company for accelerated growth both in Australia and abroad.

Sandon Capital Investments has announced a modest increase in its annual dividend and will begin paying fully franked dividends monthly, aiming to provide shareholders with more frequent income amid a changing economic backdrop.

Johns Lyng Group reported a modest revenue increase to $1.18 billion in FY25, driven by organic growth and key acquisitions, while agreeing to a $1.1 billion takeover scheme with Pacific Equity Partners.

Centrepoint Alliance reported a 13.5% revenue increase and a 30.6% rise in pre-tax profit for the year ended June 2025, yet net profit after tax fell by 33.7%. The company maintained its final dividend at 1.75 cents per share.